Abstract
Although there is an enormous amount of information available on omega-3 fatty acids, it is sometimes misleading, contradictory, and unsupported by scientific fact. Consumers and medical professionals may be confused regarding the potential value of omega-3 fatty acid supplements, despite having either read or heard about fish oil consumption and/or omega-3 fatty acid benefits and risks. The availability of a prescription formulation of omega-3-acid ethyl esters (P-OM3) has provided important new information that helps to dispel the myths and alleviate concerns surrounding the use of omega-3 fatty acids in clinical practice. The safety and efficacy of P-OM3, but not dietary-supplement omega-3 fatty acids, are documented in placebo-controlled trials. In general, studies using Food and Drug Administration-approved dosages of P-OM3 have not substantiated various myths surrounding the negative effects of omega-3 fatty acids. Thus, there are now evidence-based clinical guidelines for the use of omega-3 fatty acids in clinical practice.
Original language | English (US) |
---|---|
Pages (from-to) | 92-100 |
Number of pages | 9 |
Journal | Postgraduate medicine |
Volume | 120 |
Issue number | 2 |
DOIs | |
State | Published - Jul 1 2008 |
Externally published | Yes |
Keywords
- Dietary fats
- Evidence-based medicine
- Fatty acids
- Omega-3 fatty acids
- P-OM3
ASJC Scopus subject areas
- Medicine(all)